Prokineticin Receptor 2 (PROKR2) Peptid
-
- Target Alle Prokineticin Receptor 2 (PROKR2) Produkte
- Prokineticin Receptor 2 (PROKR2)
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Verwendungszweck
- Prokineticin Receptor 2 (extracellular) Negative Control Antigen
- Sequenz
- (C)DQNGNTSFAP DLN, correspond ing to amino acid residues 3-15 of rat PROKR2 (Accession Q8R415).
- Produktmerkmale
- Synthetic peptide, A Blocking peptide for Anti-Prokineticin Receptor 2 (extracellular) Antibody (ABIN7043561 and ABIN7045111)). Intended to be used as a negative control.
- Reinheit
- >70 %
-
-
- Applikationshinweise
- Antigen Preadsorption Control: 1 μg peptide per 1 μg antibody.
- Kommentare
-
Confirmed by amino acid analysis and mass spectrometry.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- 100 μL double distilled water (DDW).
- Konzentration
- 0.4 mg/mL
- Lagerung
- RT,-20 °C
- Informationen zur Lagerung
- Lyophilized powder can be stored intact at room temperature for two weeks. For longer periods, it should be stored at -20°C.
-
- Target
- Prokineticin Receptor 2 (PROKR2)
- Synonyme
- GPR73L1 Peptide, GPR73b Peptide, GPRg2 Peptide, HH3 Peptide, KAL3 Peptide, PKR2 Peptide, dJ680N4.3 Peptide, Gpr73l1 Peptide, B830005M06Rik Peptide, EG-VEGRF2 Peptide, Gpcr73l1 Peptide, prokineticin receptor 2 Peptide, prokineticin receptor 1 Peptide, PROKR2 Peptide, Prokr2 Peptide, PROKR1 Peptide
- Gen-ID
- 192649
- NCBI Accession
- NM_144773
- UniProt
- Q8R415
-